2025 changed what’s possible for follicular lymphoma. Science moved faster and the community spoke louder. We are not waiting. Watch FLF CEO Emma France’s message and see the progress your support helped drive. Read more: https://t.co/PSJTFXLC6b

We look forward to sharing more detailed updates and analysis from ASH in the new year.

1️⃣ Focus on FL – an increasing number of studies on innovative treatment options. 2️⃣ Chemo-free, immune-based therapies – advances are changing the game! 3️⃣ Empowering patients in shared decision-making.

At #ASH2025 last week, our Chief Medical Officer, Dr Mitchell Smith, reflected on key takeaways from the weekend and conversations with colleagues across the lymphoma field. Here are his top three insights from ASH. 👇

We look forward to sharing more detailed updates and analysis from ASH in the new year. Read more on Prof Okosun's highlights:

Her top three insights from ASH: 1️⃣ Breakthrough clinical trial results on triplet therapy combination 2️⃣ Bispecific Antibodies show promise in FL treatment 3️⃣ Fascinating advances in understanding the FL biology around relapse

At #ASH2025 this week, our Scientific Advisor Prof Jessica Okosun shared with us her key scientific and clinical highlights from the weekend. Her top three insights from ASH👇

At #ASH2025, we were glad to once again bring together FLF supported investigators for a workshop on collaboration and patient driven science in follicular lymphoma 🔬🤝. Reconnecting and building on past conversations is how we accelerate progress and move closer to a cure.

Today at #ASH2025, we were proud to host our Satellite Symposium on advancing chemotherapy free, precision care for follicular lymphoma. Thank you to the experts, attendees, and everyone who shared their insights through our global patient survey and workshops.

We’re on the ground at #ASH2025 with one goal: making sure follicular lymphoma and patient voices are part of the most important scientific conversations. We’re sharing insights from our global patient survey, convening experts, and strengthening partnerships.

On Giving Tuesday, it's time to act. Please join us in supporting groundbreaking research with the potential to unlock a cure for #FollicularLymphoma. Donʼt wait. Act now. Donate via our website: https://t.co/JWsPUYTlV6 Thank you.

U.S. treatment update for follicular lymphoma: On Nov 18, 2025, the FDA approved epcoritamab-bysp (EPKINLY®) with rituximab and lenalidomide for adults with relapsed or refractory FL after at least one prior therapy. Applies to U.S. patients. https://t.co/qYaBEUiJg4

Missed our webinar on Choosing Your Next Treatment: What FL Patients Should Know? Watch the full recording here: https://t.co/70BozZfkEN #FollicularLymphoma

Delighted to welcome Patient Advocate Nicky Greenhalgh to London! From celebrating 10 years of Living with FL (now 15k+ members) to recording a podcast with Nicola Mendelsohn and speaking at the Unlock the Cure Gala - Nicky truly inspired us. Watch: https://t.co/oJ2IxCxPE6

Huge thanks to everyone who joined our Patient Meet-Up in London last Tuesday to celebrate the Living with Follicular Lymphoma Facebook group. 💜

💜 Meet the Panelists! 📅 Webinar: Choosing your next treatment: What FL patients should know 🗓️ Thurs, Nov 20 | 6am PT · 9am ET · 2pm GMT · 10pm UTC 🎙️ Prof Kim Linton, Ari Akerstein & Dr Mitchell Smith Free & open to all ➡️ https://t.co/88jLo4vWJa

Huge thanks to everyone who joined or supported our Unlock the Cure Gala. Your generosity has helped us raise an incredible £900,000 so far. Together, we’re funding groundbreaking research and moving closer to a future where “incurable” no longer exists.

Honoured to have our Global CEO represent the Follicular Lymphoma Foundation at the Milken Future of Health Summit in DC - inspiring conversations, impactful meetings, and powerhouse women leading the charge. 💜 #FollicularLymphoma

Join us for our next webinar!​ Choosing Your Next Treatment: What FL Patients Should Know. ​ ​📅 Thursday 20 November 2025​ 🕑 6am PT | 9am ET | 2pm UK | 10pm UTC​ 🎥 Free and open to all​ ​ 🔗 Register here: https://t.co/RcwQc0mLEm​ ​ #FollicularLymphoma

Last week our CMO, Dr Mitchell Smith, alongside Dr Mike Carleton from the @TheMarkFdn met with our FL Biomarker Discovery Program research teams. By sharing insights and working together, we can move research forward faster and bring us closer to a cure.